Recombinant multi-species ARFGEF2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ARFGEF2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
ADP-ribosylation factors (ARFs) play an important role in intracellular vesicular trafficking. The protein encoded by this gene is involved in the activation of ARFs by accelerating replacement of bound GDP with GTP and is involved in Golgi transport. It contains a Sec7 domain, which may be responsible for its guanine-nucleotide exchange activity and also brefeldin A inhibition. [provided by RefSeq, Jul 2008]
The Alternative Names of target: ADP-ribosylation factor guanine nucleotide-exchange factor 2,ARFGEF2,Arfgef2,BIG2,Big2,Brefeldin A-inhibited GEP 2,Brefeldin A-inhibited guanine nucleotide-exchange protein 2,E230011G24Rik,PVNH2,dJ1164I10.1
Go
to ARFGEF2 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP3647-Ag-1/ GM-Tg-hg-IP3647-Ag-2 | Human ARFGEF2 protein | Human |
| GM-Tg-rg-IP3647-Ag-1/ GM-Tg-rg-IP3647-Ag-2 | Rat ARFGEF2 protein | Rat |
| GM-Tg-mg-IP3647-Ag-1/ GM-Tg-mg-IP3647-Ag-2 | Mouse ARFGEF2 protein | Mouse |
| GM-Tg-cynog-IP3647-Ag-1/ GM-Tg-cynog-IP3647-Ag-2 | Cynomolgus/Rhesus macaque ARFGEF2 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP3647-Ag-1/ GM-Tg-felg-IP3647-Ag-2 | Feline ARFGEF2 protein | Feline |
| GM-Tg-cang-IP3647-Ag-1/ GM-Tg-cang-IP3647-Ag-2 | Canine ARFGEF2 protein | Canine |
| GM-Tg-bovg-IP3647-Ag-1/ GM-Tg-bovg-IP3647-Ag-2 | Bovine ARFGEF2 protein | Bovine |
| GM-Tg-equg-IP3647-Ag-1/ GM-Tg-equg-IP3647-Ag-2 | Equine ARFGEF2 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP3647-Ag-1/ GM-Tg-hg-IP3647-Ag-2;
GM-Tg-rg-IP3647-Ag-1/ GM-Tg-rg-IP3647-Ag-2;
GM-Tg-mg-IP3647-Ag-1/ GM-Tg-mg-IP3647-Ag-2; GM-Tg-cynog-IP3647-Ag-1/ GM-Tg-cynog-IP3647-Ag-2; GM-Tg-felg-IP3647-Ag-1/ GM-Tg-felg-IP3647-Ag-2; GM-Tg-cang-IP3647-Ag-1/ GM-Tg-cang-IP3647-Ag-2; GM-Tg-bovg-IP3647-Ag-1/ GM-Tg-bovg-IP3647-Ag-2; GM-Tg-equg-IP3647-Ag-1/ GM-Tg-equg-IP3647-Ag-2 |
| Products Name | ARFGEF2 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | ARFGEF2 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ARFGEF2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.